Overview
- Germany’s vaccine advisory body now advises a single quadrivalent A/C/W/Y dose for children aged 12 to 14, with catch-up eligibility through the 25th birthday and administration possible at the J1 checkup.
- The long‑standing recommendation to give toddlers a MenC shot is withdrawn because type C disease has fallen to sporadic cases, as overall meningococcal incidence has declined to about 0.4 per 100,000 in 2024.
- Infant protection against meningococcal B remains in place, with doses at 2, 4 and 12 months and catch‑up recommended through age five.
- Rollout into routine practice and reimbursement by statutory health insurers require additional steps, so availability and coverage are expected to take a few months.
- Officials highlight that the policy’s population impact is estimated from modeling with limited direct clinical effectiveness data, even as the illness remains severe with reported fatality rates of roughly 7–15%.